Form 4: Worksport Director Ned Siegel Receives Option Repricing and New Option Grants
SEC Form 4
Director Ned Siegel reports repricing of existing stock options and grant of new stock options in Worksport Ltd.
Summary
- Director Ned L. Siegel filed a Form 4 detailing changes in beneficial ownership of Worksport Ltd. securities.
- On July 23, 2024, Siegel's existing stock options were repriced to $0.7042 per share.
- Siegel also received new grants of non-qualified stock options and stock options with varying exercise prices and vesting schedules.
- The options are exercisable for common stock and expire at various dates in the future.
Sentiment
Score: 6
Explanation: The document is neutral, simply reporting option repricing and grants. The impact on the company is dependent on the director's future performance.
Positives
- The repricing of options to a lower exercise price of $0.7042 could incentivize the director to improve company performance.
- The grant of new options with varying vesting schedules aligns the director's interests with the long-term success of the company.
Risks
- The repricing of options could be viewed negatively by shareholders if the original option prices were significantly higher, as it dilutes shareholder value.
- The vesting schedules of the options may not provide immediate incentive for performance.
Industry Context
Option grants and repricings are common practices to incentivize executives and align their interests with shareholders, particularly in growth-oriented companies.
Comparison to Industry Standards
- Stock option grants are a standard component of executive compensation packages in publicly traded companies, especially in the technology and manufacturing sectors.
- Repricing of options is less common but can occur when the stock price has declined significantly, to maintain the incentive value of the options.
- Companies like Tesla, Ford, and Rivian also use stock options as part of their compensation packages for directors and executives.
Stakeholder Impact
- Shareholders may experience dilution if the options are exercised.
- Employees may be affected by the director's performance, which is incentivized by the option grants.
Key Dates
| Date | Description |
|---|---|
| 01/01/2022 | Vesting date for 15,000 non-qualified stock options with an exercise price of $5.50. |
| 12/29/2022 | First vesting date for 30,000 non-qualified stock options with an exercise price of $2.51 (1/3 vest). |
| 12/29/2023 | Second vesting date for 30,000 non-qualified stock options with an exercise price of $2.51 (1/3 vest). |
| 12/29/2024 | Third vesting date for 30,000 non-qualified stock options with an exercise price of $2.51 (1/3 vest). |
| 07/23/2024 | Date of option repricing and new option grants. |
| 07/25/2024 | Date of Form 4 filing. |
| 08/06/2026 | Expiration date for 15,000 non-qualified stock options with an exercise price of $5.50. |
| 12/29/2026 | Expiration date for 30,000 non-qualified stock options with an exercise price of $2.51. |
| 07/21/2028 | Expiration date for 7,500 stock options with an exercise price of $3.61. |
| 07/23/2034 | Expiration date for 25,000 stock options with an exercise price of $0.7042. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.